AMBER REINECKE: Open Payments
NPI 1679962856 · CUSHING, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 22 payments from 11 companies in 2025. Trend: 2023 $675 · 2024 $1,101 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Lilly USA, LLC | 3 | $52 |
| Astellas Pharma US Inc | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
Products named: FARXIGA, BREZTRI, Veozah, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, Auvelity, REXULTI.
Industry payments across OK — which companies pay providers there.
